Početna › Leukemija › Wisconsin › Milwaukee
Kliničke studije za Leukemija u gradu Milwaukee, WI
11 studija za Leukemija traži sudionike na lokacijama u gradu Milwaukee i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
U tijeku regrutacijaOpažajna studija
- Children's Hospital of Wisconsin, Milwaukee
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
U tijeku regrutacijaFaza 3
- Froedtert & Medical College of Wisconsin, Milwaukee
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
U tijeku regrutacijaFaza 1
- Froedtert & Medical College Clinics, Milwaukee
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
U tijeku regrutacijaFaza 1/2
- Research Site, Milwaukee
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
U tijeku regrutacijaOpažajna studija
- Children's Hospital of Wisconsin, Milwaukee
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
U tijeku regrutacija
- Children's Wisconsin, Milwaukee
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
U tijeku regrutacijaFaza 2/3
- Froedtert & Medical College of Wisconsin, Milwaukee
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
U tijeku regrutacijaFaza 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
U tijeku regrutacijaFaza 1
- Medical College of Wisconsin Cancer Center, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Milwaukee
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
U tijeku regrutacijaOpažajna studija
- CIBMTR, Milwaukee
Studije za Leukemija u drugim gradovima
- Houston, TX28 studija
- Boston, MA25 studija
- New York City, NY19 studija
- Los Angeles, CA16 studija
- Chicago, IL16 studija
- Durham, NC13 studija
- Baldwin Park, CA12 studija
- Columbus, OH12 studija
- Nashville, TN12 studija
- Philadelphia, PA12 studija
- Atlanta, GA11 studija
- Seattle, WA11 studija
Ostale studije u gradu Milwaukee
- Rak dojke23 studija
- Nemikrocelularni karcinom pluća22 studija
- Rak (sve vrste)22 studija
- Rak pluća21 studija
- Multipli mijelom21 studija
- Rak prostate20 studija
- Folikularni limfom19 studija
- Rak gušterače18 studija
- Non-Hodgkinov limfom18 studija
- Rak jajnika17 studija
- Akutna mijeloična leukemija17 studija
- Burkittov limfom16 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.